Case C-473/22, Mylan: Judgment of the Court (Third Chamber) of 11 January 2024 (request for a preliminary ruling from the markkinaoikeus (Finland)) — Mylan AB v Gilead Sciences Finland Oy, Gilead Biopharmaceutics Ireland UC, Gilead Sciences Inc. (Reference for a preliminary ruling — Intellectual and industrial property — Medicinal product for human use — Supplementary protection certificate (SPC) — Directive 2004/48/EC — Article 9(7) — Placing on the market of products infringing SPC rights — Provisional measures ordered on the basis of an SPC — Subsequent invalidity of the SPC and revocation of the measures — Consequences — Right to appropriate compensation for losses caused by the provisional measures — Liability of the applicant for those measures for losses caused by them — National legislation providing for strict liability)